Mexican Population Threatened By Diabetes - What Are The Major Challenges?
Main Category: DiabetesArticle Date: 21 Jun 2008 - 8:00 PDT
| Patient / Public: | ![]() |
3 (1 votes) |
| Healthcare Prof: | ![]() |
2 (1 votes) |
Frost & Sullivan will host a live briefing on Wednesday, June 25, at 3:00pm EDT to provide industry participants an overview of a recently published study focusing on the Diabetes Market in Mexico.
Currently, there are more than 10 million diabetics, from which only 20% is following a correct treatment, in Mexico. Population growth and aging are two of the factors that keep increasing the potential for this market. New brands and products have already been introduced into this market so far, splitting the diabetes therapy business in three segments: insulin, anti diabetes drugs and self monitoring accessories. Therefore, pharmaceutical companies face a tough competitive environment to gain public and private healthcare sectors' share. Highlights of the briefing include: main drivers and restraints, as well as the major challenges that both, public and private sectors, will confront.
This briefing is based upon ongoing Healthcare industry analysis and it will benefit everyone involved in the diabetes market: companies which provide any diabetes therapy products, as well as public and private healthcare institutions.
"The diabetes market growth in Mexico is starting to impact on the structure and functioning of the healthcare system. Not only the public healthcare sector, but also the diabetes therapy providers will confront major challenges. However, good opportunities for suppliers will arise as long as they can deal with the competitive environment," reveals María Clark, Research Analyst for Frost & Sullivan.
Frost & Sullivan will hold this live briefing at 2pm CDT / 3:00pm EDT on Wednesday, June 25, 2008, which will provide industry participants an outlook on the Diabetes Market in Mexico. To participate, please e-mail José María Jantus at jjantus_pr@frost.com with the following information: your full name, company name, title, telephone number, e-mail address, city, state, and country. Upon receipt of the above information, a registration link will be e-mailed to you.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, partners with clients to accelerate their growth. The company's TEAM Research, Growth Consulting and Growth Team Membership empower clients to create a growth-focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents.
Frost & Sullivan
Visit our diabetes section for the latest news on this subject.
MLA
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/112263.php>
APA
http://www.medicalnewstoday.com/releases/112263.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.





